B

Bionyra Pharma

Latest funding round: 165 M$

B

• City : Paris
• Round : Série A
• Sector : Health

Bionyra Pharma develops mono- and multispecific antibodies for immune-mediated inflammatory diseases. Its treatments target atopic dermatitis and inflammatory bowel disease, where options remain insufficient.